La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Guangdong Zhongsheng Pharmaceutical Bilan de santé
Santé financière contrôle des critères 6/6
Guangdong Zhongsheng Pharmaceutical has a total shareholder equity of CN¥4.6B and total debt of CN¥429.4M, which brings its debt-to-equity ratio to 9.4%. Its total assets and total liabilities are CN¥6.2B and CN¥1.6B respectively. Guangdong Zhongsheng Pharmaceutical's EBIT is CN¥281.6M making its interest coverage ratio -33.9. It has cash and short-term investments of CN¥1.6B.
Informations clés
9.4%
Ratio d'endettement
CN¥429.45m
Dette
| Ratio de couverture des intérêts | -33.9x |
| Argent liquide | CN¥1.64b |
| Fonds propres | CN¥4.58b |
| Total du passif | CN¥1.65b |
| Total des actifs | CN¥6.23b |
Mises à jour récentes de la santé financière
These 4 Measures Indicate That Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Is Using Debt Reasonably Well
Jul 12
Does Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Have A Healthy Balance Sheet?
Mar 18Recent updates
These 4 Measures Indicate That Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Is Using Debt Reasonably Well
Jul 12Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) P/E Is On The Mark
Jun 18Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Has Affirmed Its Dividend Of CN¥0.20
May 20We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings
Apr 29Does Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Have A Healthy Balance Sheet?
Mar 18Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) Shares Climb 29% But Its Business Is Yet to Catch Up
Feb 29Analyse de la situation financière
Passif à court terme: 002317's short term assets (CN¥3.6B) exceed its short term liabilities (CN¥826.0M).
Passif à long terme: 002317's short term assets (CN¥3.6B) exceed its long term liabilities (CN¥821.2M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 002317 has more cash than its total debt.
Réduire la dette: 002317's debt to equity ratio has reduced from 30.3% to 9.4% over the past 5 years.
Couverture de la dette: 002317's debt is well covered by operating cash flow (59.9%).
Couverture des intérêts: 002317 earns more interest than it pays, so coverage of interest payments is not a concern.